# Polymer embedding of membrane lungs for histological investigations of intra-device clot formation

**Authors:** Michael Kranz, Maria Stella Wagner, Daniel Pointner, Moritz Haus, Matthias Lubnow, Karla Lehle, Lars Krenkel

PMC · DOI: 10.3389/fcvm.2026.1650978 · Frontiers in Cardiovascular Medicine · 2026-02-04

## TL;DR

A new polymer embedding method allows detailed histological analysis of clot formation in membrane lungs used in ECMO treatment.

## Contribution

A novel polymer embedding protocol enables cross-sectional analysis of multi-layered deposits in membrane lungs.

## Key findings

- Polymer embedding stabilizes deposits for microtome sectioning of membrane lung hollow-fibers.
- The method allows quantification of multi-layered deposits and fiber mat spanning structures.
- Multiple staining techniques were successfully applied to examine clots in native position.

## Abstract

Extracorporeal membrane oxygenation (ECMO) is an invasive but potentially lifesaving treatment option for severe cardiac or respiratory failure. Despite its beneficial effect, coagulation-related complications, mainly due to clot formation, excessive bleeding and the accumulation of deposits in the membrane lung (ML) remain common, causing higher mortality. In this context, the formation of clots and other deposits in the ML is of particular interest. Previous histological examinations of the polymethylpentene fiber mats inside the ML could only be performed in a top view, prohibiting valid quantification and examination of the multi-layered deposits or fiber mat spanning structures. Our objective was the establishment of a polymer embedding to increase the mechanical stability of the deposits and thus enable cross-sectional microtome cutting through the ML hollow-fibers. Clinically used MLs (PLS, Getinge, Rastatt, Germany) were stabilized with a polymer resin (HistoCURE 8100). Specimens were cut out of the embedded MLs and microtome sections with a thickness of 10 µm were performed. In addition to standard histological staining with hematoxylin-eosin (HE) and Pappenheim (May-Grunwald-Giemsa), fluorescence DNA staining for nucleated cells with 4′,6-diamidino-2-phenylindole (DAPI) and SYTOX™ Green as well as immunohistochemical and immunofluorescence staining for the lysosomal enzyme myeloperoxidase (MPO) and von Willebrand factor (vWF) were established. The protocol provides a method for large volume embedding (400 mL). The cellular and extracellular deposits were securely fixed by the polymer scaffold allowing the examination of clots in MLs in native position which was not possible with conventional paraffin embedding. Multi-layered deposits and fiber mat spanning structures are no longer disrupted during specimen extraction and can now be quantified. Staining with HE, Pappenheim, DAPI, SYTOX™ Green, MPO, and vWF was successfully tested with this protocol. This method may be the foundation for new insights into the complex clotting phenomena observed in MLs.

## Linked entities

- **Chemicals:** hematoxylin-eosin (PubChem CID 86598188), 4′,6-diamidino-2-phenylindole (PubChem CID 2954)
- **Diseases:** cardiac failure (MONDO:0005252), respiratory failure (MONDO:0021113)

## Full-text entities

- **Genes:** ABCB6 (ATP binding cassette subfamily B member 6 (LAN blood group)) [NCBI Gene 10058] {aka ABC, LAN, MTABC3, PRP, umat}, MPO (myeloperoxidase) [NCBI Gene 4353], Mpo (myeloperoxidase) [NCBI Gene 17523] {aka mKIAA4033}, VWF (von Willebrand factor) [NCBI Gene 7450] {aka F8VWF, VWD}
- **Diseases:** ML (MESH:D015433), lung or heart failure (MESH:D006333), dehydration (MESH:D003681), coagulation (MESH:D001778), clot (MESH:D013927), PLS (MESH:D010214), cardiac or respiratory failure (MESH:D012131), bleeding (MESH:D006470), PLS (MESH:D003638)
- **Chemicals:** 4',6-diamidino-2-phenylindole (MESH:C007293), formol (MESH:D005557), PBS (MESH:D007854), KCl (MESH:D011189), Eosin (MESH:D004801), SYTOX  Green (MESH:C402795), polyurethane (MESH:D011140), DAB (MESH:C000469), paraformaldehyde (MESH:C003043), tetramethylrhodamine isothiocyanate (MESH:C009434), citric (MESH:D019343), CO2 (MESH:D002245), Tris (MESH:D014325), May (MESH:C104457), Mayer's hemalum (MESH:C032807), hematoxylin (MESH:D006416), PMP (MESH:C021245), AlexaFluor 594, 711 (-), H2O2 (MESH:D006861), ethanol (MESH:D000431), tungsten-carbide (MESH:C002802), CaCl2 (MESH:D002122), silicone (MESH:D012828), HCl (MESH:D006851), acetic acid (MESH:D019342), TBS (MESH:D013725), NDS (MESH:C011442), water (MESH:D014867), Polymer (MESH:D011108), xylene (MESH:D014992), Paraffin (MESH:D010232), NaCl (MESH:D012965), methanol (MESH:D000432)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** G222E, R16D

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12913521/full.md

## Figures

12 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12913521/full.md

## References

41 references — full list in the complete paper: https://tomesphere.com/paper/PMC12913521/full.md

---
Source: https://tomesphere.com/paper/PMC12913521